U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12ClNO2.ClH
Molecular Weight 250.122
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ARBACLOFEN HYDROCHLORIDE

SMILES

Cl.NC[C@H](CC(O)=O)C1=CC=C(Cl)C=C1

InChI

InChIKey=WMNUVYYLMCMHLU-QRPNPIFTSA-N
InChI=1S/C10H12ClNO2.ClH/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14;/h1-4,8H,5-6,12H2,(H,13,14);1H/t8-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C10H12ClNO2
Molecular Weight 213.661
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Arbaclofen (STX209, R-baclofen), a selective agonist of GABA-B receptors, has been investigated in clinical trials for the treatment of autism spectrum disorder ASD, phase II and for the treatment of patients with fragile X syndrome in phase III. As a result, the drug did not meet the primary outcome of improved social avoidance in FXS in either study. In spite of positive results in some children with ASD, further study will be needed to replicate and extend these initial findings. Arbaclofen has also been investigated in phase III clinical trials as a treatment for spasticity due to multiple sclerosis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

5 mg BID to 15 mg TID
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:18:46 GMT 2025
Edited
by admin
on Mon Mar 31 18:18:46 GMT 2025
Record UNII
8703929ITD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ARBACLOFEN HYDROCHLORIDE
Common Name English
(R)-BACLOFEN HYDROCHLORIDE
Preferred Name English
BACLOFEN HYDROCHLORIDE, R-
Common Name English
BACLOFEN (R)-FORM HYDROCHLORIDE [MI]
Common Name English
BACLOFEN HYDROCHLORIDE, R(-)-
Common Name English
D-BACLOFEN HYDROCHLORIDE
Common Name English
BENZENEPROPANOIC ACID, .BETA.-(AMINOMETHYL)-4-CHLORO-, HYDROCHLORIDE (1:1), (.BETA.R)-
Common Name English
(R)-4-AMINO-3-(4-CHLOROPHENYL)BUTANOIC ACID HYDROCHLORIDE
Systematic Name English
BACLOFEN HYDROCHLORIDE, (R)-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29696
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
Code System Code Type Description
CAS
63701-55-3
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY
FDA UNII
8703929ITD
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY
PUBCHEM
44601
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY
NCI_THESAURUS
C90888
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY
MERCK INDEX
m2200
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID40213112
Created by admin on Mon Mar 31 18:18:46 GMT 2025 , Edited by admin on Mon Mar 31 18:18:46 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY